Comparison of the effects of empagliflozin and sitagliptin, as an add-on to metformin, on cardio-metabolic and glycemic parameters of patients with type 2 diabetes mellitus: a randomized, double-blind clinical trial.
Saved in:
| Title: | Comparison of the effects of empagliflozin and sitagliptin, as an add-on to metformin, on cardio-metabolic and glycemic parameters of patients with type 2 diabetes mellitus: a randomized, double-blind clinical trial. |
|---|---|
| Authors: | Mesri Alamdari, Naimeh1 (AUTHOR), Barghaman, Maryam1 (AUTHOR), Roshanravan, Neda2 (AUTHOR), Mobasseri, Majid1 (AUTHOR), Tutunchi, Helda1 (AUTHOR), Baharami, Amir1 (AUTHOR), Aliasgarzadeh, Akbar1 (AUTHOR), Sadra, Vahideh1 (AUTHOR) Sadra.vahideh@gmail.com |
| Source: | BMC Research Notes. 7/31/2025, Vol. 18 Issue 1, p1-10. 10p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 17560500 |
|---|---|
| DOI: | 10.1186/s13104-025-07214-2 |
